Abstract
AbstractDue to the lack of efficacy of synthetic vascular substitutes in the replacement of small-caliber arteries, vascular tissue engineering (VTE) has emerged as a promising solution to produce viable small-caliber tissue-engineered vascular grafts (TEVG). Previous studies have shown the importance of a cellular intimal layer at the luminal surface of TEVG to prevent thrombotic events. However, the cellularization of a TEVG seems to be a critical approach to consider in the development of a TEVG. To date, no standard cellularization method or cell type has been established to create the ideal TEVG by promoting its long-term patency and function. In this review, advances in VTE are described and discussed with a particular focus on the construction approaches of cellularized small-caliber TEVGs, the cell types used, as well as their preclinical and clinical applications.
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Developmental Biology,Biomedical Engineering,Medicine (miscellaneous)
Reference81 articles.
1. Writing Group Members. et al. Heart disease and stroke statistics—2016 update: a report from the American Heart Association. Circulation 133, e38–e360 (2016).
2. Roth, G. A. et al. Demographic and epidemiologic drivers of global cardiovascular mortality. N. Engl. J. Med. 372, 1333–1341 (2015).
3. Cardiovascular diseases (CVDs) [Internet]. World Health Organization (2021). Available from: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).
4. Pashneh-Tala, S., MacNeil, S. & Claeyssens, F. The tissue-engineered vascular graft-past, present, and future. Tissue Eng. Part B Rev. 22, 68–100 (2016).
5. Antoniou, G. A. et al. A meta-analysis of endovascular versus surgical reconstruction of femoropopliteal arterial disease. J. Vasc. Surg. 57, 242–253 (2013).
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献